Australia has recorded its second case of vaccine-induced immune thrombotic thrombocytopenia (VITT) and clinicians will have a high index of suspicion for the new syndrome associated with the AstraZeneca COVID-19 vaccine. However the risk of VITT, also known as vaccine induced prothrombotic immune thrombocytopenia (VIPIT), remains extremely low and distinguishing it from other conditions has ...
Australia well positioned to respond to COVID vaccine-induced thrombotic thrombocytopenia
By Mardi Chapman
15 Apr 2021